As a result of confirming the expression of NOX2, in our study, it was confirmed that the CF-treated group significantly decreased compared to the UUO control group, and the expression of p22phox and Rac1 was also significantly decreased. The gene discussed is CYBB; the disease is cystic fibrosis.